Who is the CEO of Vertex Pharmaceuticals? Biography
Reshma Kewalramani is the president and CEO of Vertex Pharmaceuticals, a biotechnology business based in Boston, Massachusetts. She is the first female CEO of a major biotech company in the United States. She formerly worked at Vertex as the company’s chief medical officer and vice president of global medicines development and medical affairs.
How old is Reshma Kewalramani? – Age
She is 49 years old as of 2022. She was born in 1973 in Mumbai, India.
Reshma Kewalramani Family – Education
When she was 11 years old, she and her family moved to the United States. She earned a Phi Beta Kappa, Summa Cum Laude, Phi Beta Kappa, Phi Beta Kappa, Phi Beta Kappa, Phi Beta Kappa, Phi Beta Kappa, Phi Beta Kappa, Phi Beta Kappa, Phi Beta Kappa, Ph She completed her internship and residency at Massachusetts General Hospital, as well as a dual fellowship in nephrology at Massachusetts General Hospital and Brigham and Women’s Hospital. She undertook transplantation research after completing her clinical nephrology residency. In 2015, she graduated from Harvard Business School’s General Management Program.
Reshma Kewalramani Husband – Sons
Kewalramani is not married. She has twin sons and together lives in Massachusetts.
Who is the CEO of Vertex Pharmaceuticals? – Career
Kewalramani started her medical career at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston. She worked at both the Massachusetts Eye and Ear Infirmary and the Massachusetts Institute of Technology as a physician. She subsequently moved into the biopharmaceutical industry, where she spent almost a decade at Amgen, where she held senior research and development responsibilities. She joined Vertex Pharmaceuticals in 2017. She joined the Vertex Board of Directors and assumed the role of president and CEO on April 1, 2020.
Vertex has brought Trikafta, a cystic fibrosis medicine, into the clinic, as well as VX-147, an investigational apolipoprotein L1 inhibitor for APOL1-mediated kidney illness, and pain initiatives. In addition, the company has teamed up with CRISPR Therapeutics to research gene-editing medicines for sickle cell disease and beta-thalassemia.
She has received the American College of Physicians Associates Council Award, the Janet M. Glasgow Memorial Achievement Citation from the American Medical Women’s Association, and the Harvard Medical School Excellence in Teaching Award. Kewalramani is a Fellow of the American Society of Nephrology and was board-certified in Internal Medicine and Nephrology in 2001 and 2003, respectively. She is a member of the Biomedical Science Careers Program’s board of directors and the Dean’s Advisory Committee at Boston University School of Medicine. She was named one of the Boston Business Journal’s Power 50 in 2019 and earned the TiE Boston Healthcare Leadership Award. Kewalramani was nominated to Indiaspora’s inaugural Business Leaders List in 2020.
How much does the CEO of Vertex make? – Reshma Kewalramani Salary
She earns an annual estimated net worth salary of $9.1M.
Reshma Kewalramani Net Worth
She has an estimated net worth of $29.1 Million.